4//SEC Filing
Kiely John 4
Accession 0001628280-24-049297
CIK 0001723128other
Filed
Nov 25, 7:00 PM ET
Accepted
Nov 26, 4:41 PM ET
Size
8.1 KB
Accession
0001628280-24-049297
Insider Transaction Report
Form 4
Kiely John
Director
Transactions
- Sale
Class A Common Stock
2024-11-22$8.38/sh−17,058$142,946→ 267,175 total - Exercise/Conversion
Class A Common Stock
2024-11-22$4.76/sh+28,506$135,689→ 284,233 total - Exercise/Conversion
Stock Option
2024-11-22−28,506→ 0 totalExercise: $4.76Exp: 2029-12-14→ Class A Common Stock (28,506 underlying)
Footnotes (2)
- [F1]Reflects shares sold to cover the exercise price arising in connection with the exercise of the stock options.
- [F2]The option is vested and currently exercisable.
Documents
Issuer
Amneal Pharmaceuticals, Inc.
CIK 0001723128
Entity typeother
Related Parties
1- filerCIK 0001781149
Filing Metadata
- Form type
- 4
- Filed
- Nov 25, 7:00 PM ET
- Accepted
- Nov 26, 4:41 PM ET
- Size
- 8.1 KB